293 related articles for article (PubMed ID: 26239855)
1. [Non-invasive prenatal testing is a breakthrough in prenatal screening].
Hornstrup LS; Ambye L; Sørensen S; Jørgensen FS
Ugeskr Laeger; 2015 Jul; 177(28):. PubMed ID: 26239855
[TBL] [Abstract][Full Text] [Related]
2. Cell-Free DNA Testing for Fetal Chromosomal Anomalies in clinical practice: Austrian-German-Swiss Recommendations for non-invasive prenatal tests (NIPT).
Schmid M; Klaritsch P; Arzt W; Burkhardt T; Duba HC; Häusler M; Hafner E; Lang U; Pertl B; Speicher M; Steiner H; Tercanli S; Merz E; Heling KS; Eiben B
Ultraschall Med; 2015 Oct; 36(5):507-10. PubMed ID: 26468773
[No Abstract] [Full Text] [Related]
3. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
[TBL] [Abstract][Full Text] [Related]
4. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
Shaw SW; Chen CP; Cheng PJ
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
[TBL] [Abstract][Full Text] [Related]
5. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center.
Manegold-Brauer G; Berg C; Flöck A; Rüland A; Gembruch U; Geipel A
Arch Gynecol Obstet; 2015 Sep; 292(3):543-8. PubMed ID: 25716672
[TBL] [Abstract][Full Text] [Related]
6. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
O'Leary P; Maxwell S; Murch A; Hendrie D
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
Fairbrother G; Burigo J; Sharon T; Song K
J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
[TBL] [Abstract][Full Text] [Related]
8. Clinical perspective of cell-free DNA testing for fetal aneuploidies.
Gratacós E; Nicolaides K
Fetal Diagn Ther; 2014; 35(3):151-5. PubMed ID: 24931002
[TBL] [Abstract][Full Text] [Related]
9. An update on current prenatal testing options: first trimester and noninvasive prenatal testing.
Latendresse G; Deneris A
J Midwifery Womens Health; 2015; 60(1):24-36; quiz 111. PubMed ID: 25712277
[TBL] [Abstract][Full Text] [Related]
10. Cell-free DNA screening for trisomy is rolled out in Israel.
Petherick A
Lancet; 2013 Sep; 382(9895):846. PubMed ID: 24020067
[No Abstract] [Full Text] [Related]
11. Second tier non-invasive prenatal testing in a regional prenatal diagnosis service unit: a retrospective analysis and literature review.
Ng VKS; Chan AL; Lau WL; Leung WC
Hong Kong Med J; 2020 Feb; 26(1):10-18. PubMed ID: 32051331
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive prenatal detection of aneuploidy.
Robinson C; van den Boom D; Bombard AT
Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive prenatal testing.
Harraway J
Aust Fam Physician; 2017 Oct; 46(10):735-739. PubMed ID: 29036772
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
[TBL] [Abstract][Full Text] [Related]
15. Positive view and increased likely uptake of follow-up testing with analysis of cell-free fetal DNA as alternative to invasive testing among Danish pregnant women.
Miltoft CB; Rode L; Tabor A
Acta Obstet Gynecol Scand; 2018 May; 97(5):577-586. PubMed ID: 29350746
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.
Grace MR; Hardisty E; Dotters-Katz SK; Vora NL; Kuller JA
Obstet Gynecol Surv; 2016 Aug; 71(8):477-87. PubMed ID: 27526871
[TBL] [Abstract][Full Text] [Related]
17. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
18. [Non-invasive genetic tests for fetal trisomy 21 detection: current considerations].
Benachi A; Costa JM
J Gynecol Obstet Biol Reprod (Paris); 2014 Mar; 43(3):195-7. PubMed ID: 24529921
[No Abstract] [Full Text] [Related]
19. Still a screening test: more attention needed to noninvasive prenatal test false-positive rates.
Reiss RE; Cherry AM
Am J Obstet Gynecol; 2013 Aug; 209(2):160-1. PubMed ID: 23583784
[No Abstract] [Full Text] [Related]
20. The role of noninvasive prenatal testing as a diagnostic versus a screening tool--a cost-effectiveness analysis.
Ohno M; Caughey A
Prenat Diagn; 2013 Jul; 33(7):630-5. PubMed ID: 23674316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
